A. Haciefendi And G. G. Eskiler, "The suppression of ATR/Chk1 pathway by Elimusertib ATR inhibitor in triple negative breast cancer cells," AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH , vol.15, no.7, pp.4902-4911, 2023
Haciefendi, A. And Eskiler, G. G. 2023. The suppression of ATR/Chk1 pathway by Elimusertib ATR inhibitor in triple negative breast cancer cells. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH , vol.15, no.7 , 4902-4911.
Haciefendi, A., & Eskiler, G. G., (2023). The suppression of ATR/Chk1 pathway by Elimusertib ATR inhibitor in triple negative breast cancer cells. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH , vol.15, no.7, 4902-4911.
Haciefendi, Ayten, And Gamze Guney Eskiler. "The suppression of ATR/Chk1 pathway by Elimusertib ATR inhibitor in triple negative breast cancer cells," AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH , vol.15, no.7, 4902-4911, 2023
Haciefendi, Ayten And Eskiler, Gamze G. . "The suppression of ATR/Chk1 pathway by Elimusertib ATR inhibitor in triple negative breast cancer cells." AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH , vol.15, no.7, pp.4902-4911, 2023
Haciefendi, A. And Eskiler, G. G. (2023) . "The suppression of ATR/Chk1 pathway by Elimusertib ATR inhibitor in triple negative breast cancer cells." AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH , vol.15, no.7, pp.4902-4911.
@article{article, author={Ayten Haciefendi And author={Gamze Guney Eskiler}, title={The suppression of ATR/Chk1 pathway by Elimusertib ATR inhibitor in triple negative breast cancer cells}, journal={AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH}, year=2023, pages={4902-4911} }